HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Branchiootic syndrome

Also Known As:
BO syndrome 1; Bos1; Branchiootic Syndrome 1; Branchiootic dysplasia
Networked: 47 relevant articles (0 outcomes, 3 trials/studies)

Disease Context: Research Results

Related Diseases

1. Infections
2. Branchiootic Syndrome 2
3. Disease Resistance
4. Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)
5. Wounds and Injuries (Trauma)

Experts

1. Fillinger, Sabine: 4 articles (10/2020 - 07/2008)
2. Schnabel, Guido: 3 articles (01/2017 - 04/2014)
3. Fernández-Ortuño, Dolores: 3 articles (11/2016 - 04/2014)
4. Grabke, Anja: 3 articles (08/2015 - 04/2014)
5. Hahn, Matthias: 2 articles (01/2017 - 01/2017)
6. Li, Xingpeng: 2 articles (04/2015 - 04/2014)
7. Leroux, Pierre: 2 articles (01/2012 - 07/2008)
8. Liu, Weiwei: 2 articles (04/2011 - 07/2008)
9. Mengiste, Tesfaye: 2 articles (12/2010 - 11/2003)
10. Li, Xinghai: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Branchiootic syndrome:
1. Histidine KinaseIBA
2. Membrane Proteins (Integral Membrane Proteins)IBA
3. procymidoneIBA
4. TaurineFDA Link
5. indicine (echinatine)IBA
6. Proteins (Proteins, Gene)FDA Link
7. iprodioneIBA
8. SNARE Proteins (SNAREs)IBA
9. Amino AcidsFDA Link
08/01/2015 - "The amino acid change I365S, I365N, or V368F + Q369H in Bos1 and H272R in SdhB by itself showed EC50 values of 3.99 to 14.73 ppm, 3.87 to 5.37 ppm, 4.81 to 15.63 ppm, and 2.071 to ≥30 ppm, respectively. "
01/01/2023 - "The bos1-1 mutation was located in chromosome 1. A T-to-A mutation in BOS1 was identified, which changed the codon from TAC to AAC, resulting in the amino acid change from tyrosine to asparagine. "
11/01/2018 - "A total of three rare missense mutations were detected, including heterozygous c.244G>A in LMNA, c.546C>G in potassium voltage‑gated channel subfamily KQT (KCNQ4) and c.1276G>A in EYA transcriptional coactivator and phosphatase 1 (EYA1), indicating a glutamic acid to lysine substitution at amino acid 82 (p.E82K) in LMNA, a p.F182L in KCNQ4 (a mutation associated with pathogenic deafness) and p.G426S in EYA1 (associated with Branchiootorenal syndrome 1 and Branchiootic syndrome 1 pathogenesis). "
04/01/2020 - "Sequence analysis of their BOs1 sequences indicated that the fludioxonil-resistant field isolate, XXtom1806, had four point mutations resulting in four amino acid changes (I365S, S531G, T565N, and T1267A) and three amino acids (I365S, S531G, and T565N) in the histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis receptors, and phosphatases domain, which associated with fludioxonil binding. "
05/01/2010 - "Isolates representing four different procymidone-resistant phenotypes (CarRDieSPrcRPyrS, CarRDieRPrcRPyrS, CarRDieRPrcRPyrR, and CarRDieRPrcRPyrR) all had nucleic acid point mutations resulting in amino acid changes at position 369 (change from glutamine to proline) as well as at amino acid position 373 (asparagine to serine) in the Bos1 gene."
10. TubulinIBA